• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
OAK
Click for more information
6.67% 6.4¢

OAKRIDGE INTERNATIONAL LIMITED

Market Cap $1.754M  ! watchlist Created with Sketch. Add to my watchlist

Oakridge International Limited is an Australia-based Internet of things (IoT) and... Oakridge International Limited is an Australia-based Internet of things (IoT) and healthcare technology company. The Company is primarily engaged in the business of selling professional healthcare technology equipment and solutions to healthcare facilities. The Company’s segments include Healthcare technology, Technology development and Geothermal projects. The Technology development segment is focused on the IoT technology. The Healthcare technology segment operates through its wholly owned subsidiary, JCT Healthcare Pty Ltd (JCT), which is a provider of technology solutions for the healthcare sector. JCT develops and distributes its own range of nurse call hardware and software solutions for use across multiple healthcare sectors including hospitals, aged care, disability care and supported independent living. The Geothermal projects segment includes Sokoria Geothermal Project, Ngebel Geothermal Project, Dairi Prima Geothermal Project and Puga Geothermal Project. More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
OAK
goodbye oaks 		23/03/12 2 1.0K
23/03/12 Last post  icurafu Comments Created with Sketch.  2  Views Created with Sketch.  1.0K 
OAK
Ann: Removal from Official List - Close on 7 Oct 		06/10/11 0 530
06/10/11 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  530 
AAS +
Ann: Annual Listing Fees- Suspension from Officia 		13/09/11 7 9.8K
13/09/11 Last post  rowser Comments Created with Sketch.  7  Views Created with Sketch.  9.8K 
OAK
Ann: Oaks Proposed Delisting 		31/08/11 0 486
31/08/11 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  486 
OAK
Ann: Minor International Completes Compulsory Acq 		29/07/11 0 521
29/07/11 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  521 
OAK
how to avoid compulsory acquisition 		21/07/11 23 3.3K
21/07/11 Last post  icurafu Comments Created with Sketch.  23  Views Created with Sketch.  3.3K 
OAK
Ann: Suspension from Official Quotation on 27 Jun 		27/06/11 11 2.2K
27/06/11 Last post  icurafu Comments Created with Sketch.  11  Views Created with Sketch.  2.2K 
OAK
Ann: Final Director's Interest Notice 		21/06/11 0 227
21/06/11 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  227 

See All Discussions arrow Created with Sketch.
(20min delay)
Last
6.4¢ 		Change
0.004(6.67%) 		Mkt cap ! $1.754M
Open High Low Value Volume
6.4¢ 6.4¢ 6.4¢ $513 8.021K

Buyers (Bids)

No. Vol. Price($)
2 14135 6.0¢
 

Sellers (Offers)

Price($) Vol. No.
6.5¢ 28474 1
Last trade - 12.20pm 15/11/2024 (20 minute delay) ?
OAK (ASX) Chart

Top Stories

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

Put simply: if 3D Printing is a gold rush, Amaero is selling shovels. Or maybe it's more like sneakers in an arms race.
Blue Star Helium sees approval for five more wells at 'Galactica/Pegasus' project in Colorado Blue Star Helium (ASX:BNL) has won approval from Colorado regulators to drill five fresh helium wells at its flagship.
CuFe sells its Crossroads gold royalty to Northern Star for $4M cash; says better than waiting for mine launch CuFe Ltd (ASX:CUF) has decided not to wait around for Northern Star's Crossroads mine to get up and running, selling its $4M royalty right.
HotCopper Highlights: Your most watched stocks for Week 46, 2024 What you - HotCopper users - were most interested in viewing and discussing this week (Week 46 of the year!)
InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain InhaleRX Ltd has received approval for a Phase 2 clinical trial to test its novel therapy IRX-211 for treatment of Breakthrough Cancer Pain
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.